Stoke Therapeutics, Inc. short interest in 2019
In 2019, Stoke Therapeutics, Inc.'s disclosed short interest ran from 2.46% of shares outstanding on 15 Oct 2019 to 4.16% on 31 Dec 2019, a change of +1.70 percentage points. The year's high was 4.16% on 31 Dec 2019 and its low 2.46% on 15 Oct 2019, averaging 3.13% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.93 days on 29 Nov 2019. Full history: Stoke Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 2.46% (15 Oct 2019)
- End of year
- 4.16% (31 Dec 2019)
- Change
- +1.70 pp
- High
- 4.16% (31 Dec 2019)
- Low
- 2.46% (15 Oct 2019)
- Average
- 3.13%
- Highest days to cover
- 9.93 (29 Nov 2019)
- SEC filings marked
- 4
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Oct 2019 | 2.46% | 7.66 | 10-Q filed, results (8-K) |
| 31 Oct 2019 | 2.60% | 7.12 | |
| 15 Nov 2019 | 2.96% | 7.07 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 3.35% | 9.93 | |
| 13 Dec 2019 | 3.23% | 7.44 | |
| 31 Dec 2019 | 4.16% | 8.50 |
See also: Stoke Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.